ArticleActa pharmaceutica Sinica. B2025

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative.

Yuanguang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.